Aumolertinib gets UK's MHRA approval for non-small cell lung cancer treatment

Aumolertinib gets UK's MHRA approval for non-small cell lung cancer treatment#Aumolertinib #UK039s #MHRA #approval #nonsmall #cell…

DATROWAY ® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer

DATROWAY ® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with…

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small…

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III…

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY ® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY ® as Part of Adjuvant Regimen for Patients with…